A blog about chemistry, drug development, science, and technology
Roche is continuing to add additional manufacturers for Tamiflu just in case. The latest addition is Cardinal Health as reported in Yahoo News.
Cardinal Health Signs Roche Tamiflu Pact: Financial News - Yahoo!
And here is the press release from Cardinal Health.
Cardinal Health will make Tamiflu in Europe and has the ability to print packaging and printed inserts in the US. It appears they will only be producing the 75 mg hard gelatin capsules.
I think this is a smart decision on Roche’s part which allows them to increase production without major capital investment on their part. It would be interesting to know how the terms of the contract and what exit clauses there may be for Roche in case the need never arises. Either that or they may just have them do a certain volume regardless. Either way, I think this is a great way to ensure a supply if needed without having to make large investments that wouldn’t be available for several years.
Technorati Tags: Roche, Tamiflu
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.313 seconds
November 2nd, 2007 at 12:15 am
Hi i have seen your site its very informative & very help full for suffer from this my site is about Message and discussion board for breast cancer survivors, recently diagnosed, and supporters to voice their questions, advice, and stories.